Purchase Order 36C24524P0037
Award Date 10/1/23
Potential Completion Date 9/30/24
Potential Value $31K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Luminex Corporation was awarded a $90,282 firm fixed price contract by the Department of Veterans Affairs to provide VERIGENE brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2020 under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, with an end date of September 30, 2021. As the prime contractor, Luminex will deliver test kits and related materials to support clinical operations at the VA...
- The Department of Veterans Affairs Veterans Health Administration awarded a $466,426.44 firm-fixed-price purchase order contract to Luminex Corp, a foreign-owned for-profit manufacturer of biological testing technologies, to provide VERIGENE REGENTS. This contract is not set aside. Luminex is a provider of proprietary multiplex diagnostic solutions, assays, reagents, and related products to government customers including the Department of Veterans Affairs, Centers for Disease Control and...
- Luminex Corporation was awarded a $91,000 firm fixed price Blanket Purchase Agreement (BPA) call contract by the Department of Veterans Affairs (VA) to provide Verigene brand reagents and supplies to the Rocky Mountain Regional VA Medical Center in Austin, Texas. The contract was awarded on October 1, 2019 under the VA's Master GSA Schedule for In Vitro Diagnostics, Reagents, and Tests, and has a period of performance through September 30, 2020. No set-aside designation was applied to this BPA...
- This federal contract award is for LUMINEX REAGENTS, provided to the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs. The $89,432.32 firm fixed price contract was awarded to Luminex Corp, a manufacturer of in-vitro diagnostic testing technologies, on August 1, 2023. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has no set-aside designation and is expected...
- Luminex Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of Veterans Affairs (VA) to provide VERIGENE brand reagents and supplies for the Rocky Mountain Regional VA Medical Center. The contract has a potential value of $0.00 and a completion date of September 30th, 2022. It was awarded on October 1st, 2021 under the VA's GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, with place of performance in Austin,...
- This is a federal contract award from the Veterans Integrated Service Network 1 (VISN 1), a civilian agency, to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The contract, valued at $95,000.00, is for the provision of LUMINEX REAGENTS. It is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and an ultimate completion date of July 31, 2026. The contract is not designated as a set-aside. Luminex Corp, the prime contractor,...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 awarded a firm-fixed-price purchase order worth $50,337.00 to Luminex Corp for maintenance and service of 11 Luminex Verigene readers and analyzers located at the Providence VA Medical Center in Rhode Island. The 3-year contract, awarded on October 21, 2023, provides preventive maintenance, repair services, and technical support for the Luminex molecular diagnostic equipment. This requirement was not set-aside for...
- This federal contract award to Luminex Corporation is for the delivery of Luminex reagents under a Blanket Purchase Agreement (BPA) call. The contract, with a ceiling value of $164,760.47, was awarded on August 1, 2021 by the Veterans Integrated Service Network 1 (VISN 1), a division of the Department of Veterans Affairs (VA). The contract is not set aside and is for COVID-19 related requirements, as indicated by the National Interest Action Code. Luminex is a manufacturer of biological...
- This federal contract award to Luminex Corp is for the provision of reagents for an analyzer. The $41,461.00 firm fixed-price delivery order was awarded on October 1, 2025 by the Veterans Integrated Service Network 5, a civilian agency, with a performance period ending on September 30, 2026. The contract was not set aside for any socioeconomic categories. Luminex Corp is a foreign-owned, for-profit manufacturer of advanced biological testing technologies, and has received numerous federal...
- This firm fixed price purchase order was awarded to Luminex Corp, a manufacturer of biological testing technologies, by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs. The $16,992.00 contract is for the delivery of a Respiratory Pathogen Panel, with a completion date of January 31, 2024. The award was made on a full and open competition basis, without the use of a set-aside. Luminex is an experienced federal contractor, having received prior awards...